KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Cash (2017 - 2025)

Twist Bioscience (TWST) has disclosed Change in Cash for 7 consecutive years, with -$22.6 million as the latest value for Q3 2023.

  • On a quarterly basis, Change in Cash fell 1025.23% to -$22.6 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$91.0 million, a 4.45% decrease, with the full-year FY2025 number at -$43.7 million, up 27.34% from a year prior.
  • Change in Cash was -$22.6 million for Q3 2023 at Twist Bioscience, down from -$5.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $256.1 million in Q4 2020 to a low of -$274.2 million in Q4 2021.
  • A 5-year average of $11.7 million and a median of -$5.7 million in 2023 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: skyrocketed 1352.62% in 2020, then crashed 1025.23% in 2023.
  • Twist Bioscience's Change in Cash stood at -$20.4 million in 2019, then surged by 1352.62% to $256.1 million in 2020, then tumbled by 207.06% to -$274.2 million in 2021, then soared by 77.69% to -$61.2 million in 2022, then skyrocketed by 63.12% to -$22.6 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Change in Cash are -$22.6 million (Q3 2023), -$5.7 million (Q2 2023), and -$1.5 million (Q1 2023).